BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

429 related articles for article (PubMed ID: 30073498)

  • 61. Differentiation of prostate cancer and stromal hyperplasia in the transition zone with histogram analysis of the apparent diffusion coefficient.
    Xiaohang L; Bingni Z; Liangping Z; Weijun P; Xiaoqun Y; Yong Z
    Acta Radiol; 2017 Dec; 58(12):1528-1534. PubMed ID: 28286980
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Differentiation of orbital lymphoma and idiopathic orbital inflammatory pseudotumor: combined diagnostic value of conventional MRI and histogram analysis of ADC maps.
    Ren J; Yuan Y; Wu Y; Tao X
    BMC Med Imaging; 2018 May; 18(1):6. PubMed ID: 29716527
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Whole-lesion apparent diffusion coefficient (ADC) histogram as a quantitative biomarker to preoperatively differentiate stage IA endometrial carcinoma from benign endometrial lesions.
    Zhang J; Yu X; Zhang X; Chen S; Song Y; Xie L; Chen Y; Ouyang H
    BMC Med Imaging; 2022 Aug; 22(1):139. PubMed ID: 35941559
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Comparison between borderline ovarian tumors and carcinomas using semi-automated histogram analysis of diffusion-weighted imaging: focusing on solid components.
    Mimura R; Kato F; Tha KK; Kudo K; Konno Y; Oyama-Manabe N; Kato T; Watari H; Sakuragi N; Shirato H
    Jpn J Radiol; 2016 Mar; 34(3):229-37. PubMed ID: 26798066
    [TBL] [Abstract][Full Text] [Related]  

  • 65. ADC histogram analysis for adrenal tumor histogram analysis of apparent diffusion coefficient in differentiating adrenal adenoma from pheochromocytoma.
    Umanodan T; Fukukura Y; Kumagae Y; Shindo T; Nakajo M; Takumi K; Nakajo M; Hakamada H; Umanodan A; Yoshiura T
    J Magn Reson Imaging; 2017 Apr; 45(4):1195-1203. PubMed ID: 27571307
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Utility of whole-lesion ADC histogram metrics for assessing the malignant potential of pancreatic intraductal papillary mucinous neoplasms (IPMNs).
    Hoffman DH; Ream JM; Hajdu CH; Rosenkrantz AB
    Abdom Radiol (NY); 2017 Apr; 42(4):1222-1228. PubMed ID: 27900458
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correlation between molecular prognostic factors and magnetic resonance imaging intravoxel incoherent motion histogram parameters in breast cancer.
    Feng W; Gao Y; Lu XR; Xu YS; Guo ZZ; Lei JQ
    Magn Reson Imaging; 2022 Jan; 85():262-270. PubMed ID: 34740800
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Differential diagnosis of benign and malignant breast masses using diffusion-weighted magnetic resonance imaging.
    Min Q; Shao K; Zhai L; Liu W; Zhu C; Yuan L; Yang J
    World J Surg Oncol; 2015 Feb; 13():32. PubMed ID: 25889380
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pathological characteristics and risk stratification in patients with stage I endometrial cancer: utility of apparent diffusion coefficient histogram analysis.
    An T; Kim CK
    Br J Radiol; 2021 Oct; 94(1126):20210151. PubMed ID: 34233478
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Discrimination between benign and malignant testicular lesions using volumetric apparent diffusion coefficient histogram analysis.
    Fan C; Min X; Feng Z; Cai W; Li B; Zhang P; You H; Xie J; Wang L
    Eur J Radiol; 2020 May; 126():108939. PubMed ID: 32171915
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Whole-lesion histogram analysis metrics of the apparent diffusion coefficient: a correlation study with histological grade of hepatocellular carcinoma.
    Xu YS; Liu HF; Xi DL; Li JK; Liu Z; Yan RF; Lei JQ
    Abdom Radiol (NY); 2019 Sep; 44(9):3089-3098. PubMed ID: 31256226
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Measuring the apparent diffusion coefficient in primary rectal tumors: is there a benefit in performing histogram analyses?
    van Heeswijk MM; Lambregts DMJ; Maas M; Lahaye MJ; Ayas Z; Slenter JMGM; Beets GL; Bakers FCH; Beets-Tan RGH
    Abdom Radiol (NY); 2017 Jun; 42(6):1627-1636. PubMed ID: 28160039
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diffusion-weighted imaging (b value = 1500 s/mm(2)) is useful to decrease false-positive breast cancer cases due to fibrocystic changes.
    Ochi M; Kuroiwa T; Sunami S; Murakami J; Miyahara S; Nagaie T; Oya M; Yabuuchi H; Hatakenaka M
    Breast Cancer; 2013 Apr; 20(2):137-44. PubMed ID: 22161277
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Whole-tumor MRI histogram analyses of hepatocellular carcinoma: Correlations with Ki-67 labeling index.
    Hu XX; Yang ZX; Liang HY; Ding Y; Grimm R; Fu CX; Liu H; Yan X; Ji Y; Zeng MS; Rao SX
    J Magn Reson Imaging; 2017 Aug; 46(2):383-392. PubMed ID: 27862582
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Could breast multiparametric MRI discriminate between pure ductal carcinoma in situ and microinvasive carcinoma?
    Rizzo V; Cicciarelli F; Galati F; Moffa G; Maroncelli R; Pasculli M; Pediconi F
    Acta Radiol; 2024 Jun; 65(6):565-574. PubMed ID: 38196268
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Computer-aided heterogeneity analysis in breast MR imaging assessment of ductal carcinoma in situ: Correlating histologic grade and receptor status.
    Chou SS; Gombos EC; Chikarmane SA; Giess CS; Jayender J
    J Magn Reson Imaging; 2017 Dec; 46(6):1748-1759. PubMed ID: 28371110
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Can MRI biomarkers at 3 T identify low-risk ductal carcinoma in situ?
    Rahbar H; Parsian S; Lam DL; Dontchos BN; Andeen NK; Rendi MH; Lehman CD; Partridge SC
    Clin Imaging; 2016; 40(1):125-9. PubMed ID: 26365872
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Volumetric Apparent Diffusion Coefficient Histogram Analysis in Differentiating Intrahepatic Mass-Forming Cholangiocarcinoma From Hepatocellular Carcinoma.
    Zou X; Luo Y; Li Z; Hu Y; Li H; Tang H; Shen Y; Hu D; Kamel IR
    J Magn Reson Imaging; 2019 Apr; 49(4):975-983. PubMed ID: 30277628
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Three-compartment spectral diffusion analysis for breast cancer magnetic resonance imaging.
    Ogawa M; Kan H; Urano M; Kawai T; Nakajima H; Murai K; Miyaji H; Toyama T; Hiwatashi A
    Magn Reson Imaging; 2023 Nov; 103():179-184. PubMed ID: 37178723
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An Apparent Diffusion Coefficient Histogram Method Versus a Traditional 2-Dimensional Measurement Method for Identifying Non-Puerperal Mastitis From Breast Cancer at 3.0 T.
    Tang Q; Li Q; Xie D; Chu K; Liu L; Liao C; Qin Y; Wang Z; Su D
    J Comput Assist Tomogr; 2018; 42(5):776-783. PubMed ID: 29787501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.